Out of Office: API Updates That You May Have Missed This SummerBy
In case you missed it, here are some recent articles from DCAT Value Chain Insights, the information resource and online publication of the Drug, Chemical & Associated Technologies Association (DCAT), providing news and analysis of the global bio/pharmaceutical manufacturing value chain—from raw materials, to intermediates, to APIs (small molecules and biologics), to drug products, to packaging and the related supply chain.
Mid-Year Review: New Drug Approvals Thus Far in 2022
As we move past the mid-way mark in 2022, how has the industry fared with new drug approvals? Is the industry keeping pace with prior years’ innovation levels? What do the numbers show, including the mix between small molecules and biologics?
Global API Market: Crunching the Numbers
Synthetic APIs, referring to pharmaceutical fine chemicals (APIs and intermediates), dominate the global API market, accounting for more than 80% of the global API market. How is the market growing, and what are key trends in global API demand and supply?
CDMOs/CMOs Expand High-Potency API Manufacturing
Growth in the oncology drug market continues to spur demand for high-potency API manufacturing. Which CDMOs/CMOs are expanding? A roundup of the latest investments.
Get these articles and weekly notifications (delivered on Fridays) of the latest from DCAT Value Chain Insights by subscribing on a complimentary basis here.